Macrobid vs. Flagyl

See how Macrobid and Flagyl compare on approved uses, dosing, side effects, and cost.

Key Takeaways

  • Macrobid is a urinary anti-infective used specifically for uncomplicated bladder infections, while Flagyl treats anaerobic bacterial infections and certain parasitic infections like trichomoniasis.

  • Macrobid concentrates in urine and has little effect elsewhere in the body, so it cannot treat infections outside the urinary tract, unlike Flagyl.

  • Flagyl requires strict alcohol avoidance and carries a boxed warning about cancer risk seen in animal studies, warnings Macrobid does not carry.

Macrobid vs. Flagyl Drug Summary

Macrobid

Macrobid (nitrofurantoin) is a urinary anti-infective that treats acute, uncomplicated bladder infections caused by susceptible bacteria like E. coli. It is taken as an oral capsule, usually twice a day for seven days, and works by concentrating in the urine rather than the bloodstream.

Flagyl

Flagyl (metronidazole) is a nitroimidazole antimicrobial that treats anaerobic bacterial infections, amebiasis, and trichomoniasis. It is taken as an oral tablet, with dosing and duration that vary widely depending on which infection it is treating.

Macrobid vs. Flagyl Side Effects

Macrobid

Most common
nausea (up to 8%)
headache (up to 6%)
flatulence (up to 1.5%)
vomiting (up to 1%)

Flagyl

Most common
nausea (up to 12%)
headache (up to 6%)
metallic taste (up to 8%)
diarrhea (up to 5%)

Macrobid vs. Flagyl Dosage

Macrobid

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 100 mg every 12 hours Days 1-7
Maximum dose 100 mg every 12 hours Same as starting
Dose changes None Fixed dose

Flagyl

Dosage
Dosage Table
STAGE DOSE WHEN
Starting dose 250 mg three times daily Days 1-7
Maximum dose 7.5 mg/kg every 6 hours Days 1-7
Dose changes 3 increases As tolerated

Macrobid vs. Flagyl Indications

Macrobid

Macrobid is FDA-approved for acute, uncomplicated urinary tract infections caused by susceptible bacteria such as E. coli. It is also commonly used off-label at lower doses for long-term prevention of recurrent UTIs.

  • Acute uncomplicated UTI (cystitis) from E. coli or S. saprophyticus

  • Off-label: low-dose prophylaxis for recurrent UTIs

  • Not approved for pyelonephritis or upper urinary tract infections

  • Not approved for children under 12 or infants under 1 month

  • Contraindicated near labor and delivery at term

Flagyl

Flagyl is FDA-approved for trichomoniasis, amebiasis, and anaerobic bacterial infections throughout the body. It is also used off-label, in a specific dosing regimen, for bacterial vaginosis.

  • Symptomatic and asymptomatic trichomoniasis

  • Treatment of sexual partners of trichomoniasis patients

  • Amebiasis (intestinal and extraintestinal)

  • Anaerobic bacterial infections

  • Off-label: bacterial vaginosis

Macrobid vs. Flagyl Pros and Cons

Macrobid

Macrobid stays concentrated in the urine, which limits its systemic side effects but also limits it strictly to bladder infections. It has been a reliable UTI treatment for decades, though it requires normal kidney function to work safely.

Pros

  • Reliably effective against E. coli even after decades of use

  • Simple twice-daily course for just seven days

  • Minimal systemic drug levels reduce some whole-body side effect risks

  • No alcohol restriction like Flagyl requires

Cons

  • Contraindicated in significant kidney impairment

  • Cannot treat infections outside the urinary tract

  • Long-term use linked to rare but serious lung and liver reactions

  • Not approved for children under 12

Flagyl

Flagyl covers a much broader range of infections than Macrobid, including anaerobic bacteria and certain parasites, and offers a convenient single-dose option for trichomoniasis. That breadth comes with a boxed cancer warning and a strict requirement to avoid alcohol during treatment.

Pros

  • Treats anaerobic infections throughout the body, not just the urinary tract

  • Single-dose option available for trichomoniasis

  • Decades of established use across many infection types

  • Available in oral, IV, and extended-release forms for different severities

Cons

  • Boxed warning for carcinogenicity seen in animal studies

  • Must avoid alcohol during and after treatment due to severe reactions

  • Contraindicated in patients with Cockayne syndrome

  • Brand-name tablets are discontinued, so only generic is available

Common Symptoms and Related Diseases You Can Explore

Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.